Philip Morris
Brief Synopsis
Fields
- Area
- WAKEHAM,HELMUT/KAROL SHARPE'S OFFICE
- Type
- REPT, OTHER REPORT
- Named Organization
- Cetus
- Standard Oil
- Request
- Stmn/R1-004
- Stmn/R1-150
- Master ID
- 1000229536/9811
Related Documents:- 1000229537-9544
- 1000229551-9552 Introduction
- 1000229553-9555 Brief History of Cetus Financing
- 1000229556-9557
- 1000229558-9560 Special Note to Investors
- 1000229561-9563 Special Note Regarding Founder's Stock
- 1000229567-9569 Board of Directors
- 1000229575-9580 Achievements of Cetus People
- 1000229581-9599 Present Cetus Activities
- 1000229600-9616 Research Plan
- 1000229617-9619 Patents
- 1000229621-9656 Debenture Purchase Agreement
- 1000229657-9661 the Cetus Story
- 1000229663-9667 Cloning Business: It's Growing Fast It's Growing Fast
- 1000229668 World Roundup
- 1000229669-9670 Latin Drive: Brazil Spends Millions to Put Alcohol in Cars and Save Oil
- 1000229671 Can US Reduce Imports with Gasoline? Some Say Yes, But Officials Are Dubious
- 1000229672-9673 Bacterial Insulin Production Hears Reality
- 1000229674 Business World
- 1000229675-9677 Who Should Play God?
- 1000229678 Schering Plough New York Analysts' Meeting December 7, 1977
- 1000229679 Indiana Standard Labels Purchase Offer Part of Move to Wider Technology Base
- 1000229680 Big Deal for Berkley Bugs
- 1000229681 Oil-Less World May Run on Bugs
- 1000229682-9685 Tinkering with Life
- 1000229686-9687 Set for Biology's New Revolution
- 1000229688 Little Black Box of Cetus
- 1000229689-9695 Industry Is Finding More Jobs for Microbes
- 1000229696-9701 Dup of Id 1000229657-9661
- 1000229702-9710 Recombinant Molecular Research at Cetus Corporation
- 1000229711-9715 New Cetus Antibiotic
- 1000229716-9720 Letter to the Shareholders
- 1000229721-9726 Letter to Shareholders
- 1000229727-9728 Letters to the Shareholders
- 1000229729-9730
- 1000229731-9734 Letter to the Shareholders
- 1000229735-9736 Letter to Shareholders
- 1000229737-9749 the Manipulation of Genes
- 1000229750-9770 Microbial Genetics and the Future of the Pharmaceutical Industry
- 1000229771-9774 Recombinant Dna: Fact and Fiction
- 1000229775-9778 Testomony of Ronald E Cape, Phd President, Cetus Corporation, Berkeley, California Before the House Subcommittee on Science, Research and Technology
- 1000229779-9797 Biosystems Poised for Growth
- 1000229798-9805 Testimony of Ronald E. Cape, Ph.D President, Cetus Corporation, Berkley, California Before the Senate Subcommittee on Science, Technology and Space
- 1000229806-9807 Statement of Ronald E. Cape, Ph.D President, Cetus Corporation, Berkeley, California Before A Special Joint Congressional Hearing in Conjunction with Oversight Hearings on Science and Technology Policy the Senate Subcommittee on Science, Technology and Space of the Commerce, Science and Transportation Committee Presiding, Senator Adlai Stevenson, III Washington, Dc
- 1000229808-9811 Statement of Ronald E. Cape, Ph.D. President, Cetus Corporation, Berkeley, California at the Annual Meeting of the American Association for the Advancement of Science Session on Recombinant Dna Public Health and Biomedical Research Policy Washington, D.C.
- Litigation
- Stmn/Produced
- Characteristic
- CONF, CONFIDENTIAL
- Site
- R37
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- dfi84e00
Document Images
%W y'.f; ^Wi~faw`~' y'Py ~~fA~3'MGM'~~R111MFw~Y~fISwJ~w~irn:i.
.r?

,.~.
fia 4
-+.4~'
~ ~Y-s
" ^".:

Brief Synopsis of Offering
Cetus Cornoration intends to offer for sale $5,000,000 of its common
stock at $18.81 per share.
The Corporation is free to offer this stock for sale only until November
17, 1978. Thereafter, Standard Oil Company (Indiana) has a right of ,
first opportunity. (Further details below.)
An opportunity may also exist to purchase a significant amount of common
stock from certain of the founders of the Corporation who have not
previously sold any significant portion of their holdings. -
Cetus Corporation has pioneered and is a leader in the:commercialization
of molecular biology. The company is presently engaged in numerous
programs in pursuit of this objective. Projects are:=currently being
conducted for client companies in the pharmaceutical, chemical, oil, and
food industries. All these clients have sales;=inJexcess-of $1,000,000,000
annually, and comprise U.S. and foreign,companies. Cetus is also de-
veloping proprietary technology for its own account.
~
GO
~ ~ti
In 1977 and 1978, Standard Oil Company ~Indiana) invested about $10,000,000
in Cetus preferred stock, common`stock; ,aind convertible debentures (now
convertible at $18.81 per commonshare).:''v One of`the stipulations of the.
Debenture Purchase Agreement(gave Standard the first right to invest the
next $9,000,000 that Cetus chooses toraise. The first $6,000,000 was
to be common stock and the remaining..$3,000y000 was to be another conver-
tible debenture. Cetus was permitted to apply for such investment twice
in any year, with a maximum of $5,000,000 on any occasion.
On April 14, 1978, the Cetus Board of Directors (the Standard repre-
sentatives abstaining) adopted unanimously a three-year research plan as
a result of which 333,333 shares of Cetus common stock were offered to
Standard for $5,000,000,"payable in cash, precisely as stipulated in the
Debenture Purchase Agreement.
i~' <ti ~'
Standard offeredto make this investment, but on two conditions:
a. That the$5. 000,000 would be paid only when and if Cetus' cash
balance (presently about.$5,000,000) fell below $1,000,000, and
further;;''
~
v ~
;
,
~
b. That "founding management" agree to restrictions on the disposition
of its stock, for the benefit of Standard.
These conditions were unacceptable to Cetus. Under the terms of the
Debenture Purchase Agreement, Cetus Corporation became free, for 180
days from May 21, 1978, to sell these securities to anyone else, on
terms no less attractive than those which Standard Oil Company (Indiana)
declined.

t
. .a ti' / .4' ~4:.:A.d~ rf 1 .. . ..._,.. ~.. _. .. . ..._ .Y . .y~. aa~.~«~ .
.. c. r'.i ~... . ^ - t,) + .
~!~~i'~sJ...t :t.t,.. y~.£'> y.'"~,'~:~ r~~ :i~~ f~.'3`.' `".:1_~~ct.'~"C.A`..`'.'.~.~ .
~....~'.J~~ ~.~y~ .-.....Y '# .. _. ~ , .;,~...,a.p. `~ ~{~.~~~'~
o.` -i`!~~ +~Z ~s. C1'.K~~: ~{~K._ t¢ ~~~}~ '~ ~y':i t __t. ~.~ ~. . .. :s ~ ,.`.+~ r~;
`.~r ` .~,, .t' ~ts-a.''
' . . 2~"Y~, ~t:l:;
.~..._ ~......_ ..
'
~'.:F
. .. .. , _ .w~.
»- 6 u t< i. vr
1 'Z, r . . ._ ~ .. .. . s L f'`;~.~h~F )..~.
.. .,_ , . . ..
~ t.: .:,3:'!`~~ n i". ~.iyt :.~it?
.ri..
~. . ~G
Y4e, / f i. ~ 3 . .'~~: 3 l,~'S .: X.. .'~ k . ~ J . ~ , ui:,' V~ . _ r. ._ ~
iS7~ O 4aL .31~.: t/ w^ :i~i+i:ir~ .
vv 'ti'~ +i k ~ iia k~§3: i .e: ~ `ei :~Cf SY . ~: r~,~~ J a~OS$` i.{ ^. ~~0 L ` :ll::+l~ k
NZp
~
h ~iO'11`
r~:..L~i~y;aL'~4.~~~ °1'(.: `F ~P . .....~l..yaG ....li~'V _ ~'.~ .3~ J 7. ~~ ,-.5..-.
._ (~ : 1"~ :S~t'TY ~
-.1t ':.J..: . .'.`~p~`.. ... .... "
p..
.. . .,
~ . .. ,._ . ..,
,~-:,: +. ";4' ~{ti 'a,..r ..::~:~~ .!.~ . ... _..~..
r,...'. ~ '``~
a~.G~~_J
4
.~ G o~ O ~
~
't~
ra ~Qr Ok
ru a iZ. L : {
. s - ~5, ,y~a' psS.
Gp~.
~rJ
~pG{'qj~
1 ,
f : J ~ '~W F{>
. ,r.~ f ~ ~:5, T ."t 3 ^wiw J ~E :'2 ~ ... "~ F t ` " .
. . _... . . _. .. ... . . . L: .. ...

This Cetus presently intends to do.
There are no other restrictions on the private sale of any of Cetus
uorporations stocx.
This presentation briefly reviews the Corporation's history and current
business and financial position. Further details . regarding Cetus'
condition and plans will be provided to interested principals.
Q
~~~v G~~~ ~ 0 40-s
.. o~-
o
^o- ,
{
a
,o
Cl .oa ~~ f ,
v IN

---
